It is likely that POLRMT inhibition/silencing only targeted the enhanced mitochondrial functions (including OXPHOS) in endometrial carcinoma cells, this explains the ineffectiveness of IMT-1 treatment/POLRMT silencing in primary endometrial epithelial cells. Here, POLRMT is linked to endometrial carcinoma.